Annamaria Bonetti

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

Marika Pane, Claudio Bruno, Gessica Vasco, 2010, Neuromuscular Disorders.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

G. Comi, S. Corti, E. Mazzone, 2022, The Lancet Neurology.

The LiberAction Project: Implementation of a Pediatric Liberation Bundle to Screen Delirium, Reduce Benzodiazepine Sedation, and Provide Early Mobilization in a Human Resource-Limited Pediatric Intensive Care Unit

M. Raponi, K. Choong, D. Biasucci, 2021, Frontiers in Pediatrics.

Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience

E. Bertini, C. Palermo, M. Pane, 2017, Neuromuscular Disorders.

Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

R. Finkel, M. Pane, A. Mayhew, 2023, Neurology and Therapy.

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys

E. Bertini, E. Mazzone, C. Palermo, 2014, PLoS currents.